These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27881271)

  • 1. Cost-Effectiveness Analysis Expands its Reach Worldwide.
    Greenberg D; Neumann PJ
    Value Health Reg Issues; 2016 Sep; 10():101-102. PubMed ID: 27881271
    [No Abstract]   [Full Text] [Related]  

  • 2. Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine.
    Padula WV; McQueen RB; Pronovost PJ
    Med Care; 2017 Nov; 55(11):909-911. PubMed ID: 29028753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-effectiveness: euros per QALY is not enough].
    van den Berg M; Hamberg-van Reenen HH; Schoemaker CG
    Ned Tijdschr Geneeskd; 2012; 156(5):A3817. PubMed ID: 22296895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of cost-effectiveness and cost-usefulness in radiology].
    Janne d'Othée B; Bettmann MA; Pirard S; Zhuang Z; Black WC
    J Radiol; 2001 Dec; 82(12 Pt 1):1687-92. PubMed ID: 11917633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness. How should it be determined?
    Beaves RG; Joseph H; Rohrer JE; Zeitler RR
    Eval Health Prof; 1988 Jun; 11(2):213-30. PubMed ID: 10312609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
    Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
    BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.
    Zethraeus N; Johannesson M; Jönsson B; Löthgren M; Tambour M
    Pharmacoeconomics; 2003; 21(1):39-48. PubMed ID: 12484802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis in pathology.
    Raab SS
    Clin Lab Med; 1999 Dec; 19(4):757-71, v-vi. PubMed ID: 10572713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit and cost-effectiveness analysis for health promotion programs.
    Barry PZ; DeFriese GH
    Am J Health Promot; 1990; 4(6):448-52. PubMed ID: 10113240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of liver cancer screening.
    Cucchetti A; Cescon M; Erroi V; Pinna AD
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):961-72. PubMed ID: 24182614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Working toward a common currency: is standardization of cost-effectiveness analysis possible?
    Luce BR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S19-22. PubMed ID: 7493194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical appraisal of the cost effectiveness of laparoscopic colorectal surgery for oncological and non-oncological resections.
    Sajid MS; Rathore MA; Baig MK; Sains P
    Updates Surg; 2017 Sep; 69(3):339-344. PubMed ID: 28493219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis for health communication programs.
    Guilkey DK; Hutchinson P; Lance P
    J Health Commun; 2006; 11 Suppl 2():47-67. PubMed ID: 17148099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness Analysis of Knee Osteoarthritis Treatment.
    Stan G; Orban H; Orban C
    Chirurgia (Bucur); 2015; 110(4):368-74. PubMed ID: 26305202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital IAPT: the effectiveness & cost-effectiveness of internet-delivered interventions for depression and anxiety disorders in the Improving Access to Psychological Therapies programme: study protocol for a randomised control trial.
    Richards D; Duffy D; Blackburn B; Earley C; Enrique A; Palacios J; Franklin M; Clarke G; Sollesse S; Connell S; Timulak L
    BMC Psychiatry; 2018 Mar; 18(1):59. PubMed ID: 29499675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Median-based incremental cost-effectiveness ratios with censored data.
    Bang H; Zhao H
    J Biopharm Stat; 2016; 26(3):552-64. PubMed ID: 26010599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa.
    Worrall E; Rietveld A; Delacollette C
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):136-40. PubMed ID: 15331829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
    Salomon JA; Weinstein MC; Hammitt JK; Goldie SJ
    JAMA; 2003 Jul; 290(2):228-37. PubMed ID: 12851278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of screening for amblyopia].
    Neubauer AS; Neubauer S
    Klin Monbl Augenheilkd; 2005 Feb; 222(2):110-6. PubMed ID: 15719314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.